Browse Title Index
| Issue | Title | |
| Vol 10, Supp. A (2019) | Długoterminowa skuteczność azacytydyny u chorej z ostrą białaczką szpikową na podłożu zmian dysplastycznych | Abstract PDF (Polish) |
| Marcin Wójtowicz | ||
| Vol 10, Supp. A (2019) | Długoterminowe leczenie azacytydyną chorego na zespół mielodysplastyczny wyższego ryzyka | Abstract PDF (Polish) |
| Grzegorz Charliński, Weronika Piszczek, Weronika Piszczek | ||
| Vol 10, Supp. C (2019) | Długotrwałe odpowiedzi na leczenie brentuksymabem vedotin u chorych na chłoniaka Hodgkina oraz chłoniaka anaplastycznego z dużych komórek | Abstract |
| Andrzej Pluta | ||
| Vol 5, No 1 (2014) | Early post-transplantation lymphoproliferative disorder with central nervous system involvement and EBV infection following allogeneic hematopoietic stem cells transplantation | Abstract PDF (Polish) HTML (Polish) |
| Barbara Nasiłowska-Adamska, Piotr Grabarczyk, Tomasz Dzieciątkowski, Jerzy Windyga, Anna Ejduk, Agnieszka Tomaszewska, Andrzej Szczepiński, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Kazimierz Hałaburda, Bożena Mariańska, Krzysztof Warzocha | ||
| Vol 10, No 2 (2019) | Editorial | Details PDF (Polish) |
| Iwona Hus | ||
| Vol 11, Supp. A (2020) | Editorial | Details PDF (Polish) |
| Iwona Hus | ||
| Vol 11, No 3 (2020) | Editorial | Details PDF (Polish) |
| Iwona Hus | ||
| Vol 12, Supp. C (2021) | Effective midostaurin treatment in a patient with aggressive systemic mastocytosis | Abstract PDF (Polish) |
| Karolina Chromik, Patrycja Rozwadowska, Grzegorz Helbig | ||
| Vol 12, No 2 (2021) | Effective midostaurin treatment in a patient with aggressive systemic mastocytosis | Abstract PDF |
| Karolina Chromik, Patrycja Rozwadowska, Grzegorz Helbig | ||
| Vol 9, No 1 (2018) | Effective rescue treatment with tyrosine kinase inhibitors of a patient with B-cell acute lymphoblastic leukemia Philadelpha-positive | Abstract PDF (Polish) |
| Ilona Seferyńska, Anna Ejduk, Iwona Solarska, Krzysztof Warzocha | ||
| Vol 14 (2023): Continuous Publishing | Effective treatment of severe forms of RSV and Pneumocystis jirovecii infections in a child with Down syndrome and acute lymphoblastic leukemia treated with chemotherapy | Abstract PDF |
| Magdalena Ostojska, Katarzyna Karska, Monika Lejman, Joanna Zawitkowska | ||
| Vol 12, No 1 (2021) | Effectiveness and safety of ixazomib–lenalidomide–dexamethasone in high-cytogenetic-risk relapsed/refractory multiple myeloma — results of the Polish Myeloma Group observational study | Abstract PDF |
| Marek Hus, Aneta Szudy-Szczyrek, Michał Mielnik, Paweł Leszek Bernatowicz, Jarosław Piszcz, Agnieszka Druzd-Sitek, Maria Czyżewska, Maciej Putowski, Krzysztof Giannopoulos | ||
| Vol 12, Supp. D (2021) | Effectiveness of combined therapy with midostaurin and standard chemotherapy and high dose chemotherapy with allogeneic stem cell transplantation in high risk acute myeloid leukemia with FLT3-TKD and NPM1 mutations | Abstract PDF |
| Elżbieta Patkowska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Barbara Nasiłowska-Adamska | ||
| Vol 2, No 2 (2011) | Effectiveness of minimal dose of lenalidomide in the treatment of relapsed plasma cell myeloma | Abstract PDF (Polish) |
| Hanna Ciepłuch, Jan Maciej Zaucha | ||
| Vol 11, No 4 (2020) | Effectiveness of pomalidomide therapy in patient with multiple myeloma refractory to other immunomodulatory drugs | Abstract PDF (Polish) |
| Marta Masternak, Marta Morawska | ||
| Vol 8, Supp. C (2017) | Effectiveness of ruxolitinib in the treatment of patients with myelofibrosis with co-morbidities | Abstract PDF (Polish) |
| Katarzyna Kotwica-Mojzych, Iwona Hus, Barbara Jodłowska-Jędrych, Mariusz Mojzych, Marek Hus | ||
| Vol 4, No 3 (2013) | Effi cacy of primary myelofi brosis therapy with JAK2 inhibitors | Abstract PDF (Polish) HTML (Polish) |
| Tomasz Sacha | ||
| Vol 8, Supp. A (2017) | Efficacy and safety of long-term pomalidomide treatment in a patient with relapsed/refractory plasma cell myeloma — case report | Abstract PDF (Polish) |
| Grzegorz Charliński, Elżbieta Wiater | ||
| Vol 5, No 4 (2014) | Efficacy and safety of tyrosine kinase inhibitors in elderly patients with chronic myelogenous leukemia | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Lewandowski | ||
| Vol 1, No 4 (2010) | Efficacy of bendamustine combined with rituximab in the treatment of relapsed chronic lymphocytic leukemia | Abstract PDF (Polish) |
| Wioletta Kamińska, Maria Luiza Kusz, Iwona Hus | ||
| Vol 5, No 2 (2014) | Efficacy of bendamustine combined with rituximab in the treatment of relapsed follicular lymphoma — a case report and review of the literature | Abstract PDF (Polish) HTML (Polish) |
| Agata Malenda, Agnieszka Kołkowska-Leśniak, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 10, Supp. C (2019) | Efficacy of brentuximab vedotin in the fourth-line treatment of primary resistant Hodgkin lymphoma | Abstract PDF (Polish) |
| Beata Kania-Zembaczyńska | ||
| Vol 12, No 1 (2021) | Efficacy of lenalidomide in the treatment of myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) with the presence of deletion 5q– and trisomy 8+ | Abstract PDF |
| Oliwia Bachanek-Mitura, Aneta Szudy-Szczyrek, Marek Hus | ||
| Vol 13, No 1 (2022) | Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features | Abstract PDF |
| Elżbieta Patkowska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Barbara Nasiłowska-Adamska | ||
| Vol 2, No 1 (2011) | Efficacy of rituximab in refractory primary immune thrombocytopenia | Abstract PDF (Polish) |
| Agnieszka Kopacz | ||
| 126 - 150 of 548 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
